Humana To Present At J.P. Morgan Healthcare Conference; Webcast At 6:45 PM ET

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Aunt Millie's Our Family White Hot Dog Buns Recalled

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update

FDA Clears Eat Just's Good Meat Cultivated Chicken

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Dyne Therapeutics Announces Orphan Drug And Rare Pediatric Designations For DYNE-251

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Generation Bio Shares Surge On Partnership With Moderna

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

Biogen Updates On FDA Advisory Committee Meeting On Tofersen For SOD1-ALS

FDA Approves Incyte's Zynyz For Skin Cancer Treatment

Pendragon FY22 Earnings Drop, But Revenue Climbs; Says Confident Of FY23

Kingfisher FY Adj. Post-tax Profit Declines; LFL Sales Down 2.1%

Playtech FY22 Profit Down, Revenues Rise; Says Strong Start To FY23

Biogen Updates On FDA Advisory Committee Meeting On Tofersen For SOD1-ALS

Heidelberg Materials Lifts Annual Dividend

Kite Reports Primary Overall Survival Analysis Results Of Phase 3 ZUMA-7 Study

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

Iovance Biotherapeutics Completes BLA Submission For Lifileucel In Advanced Melanoma

Canadian Solar Inc. Q4 Income Rises

Trupanion CFO Drew Wolff To Step Down Effective June 1

HORNBACH Group FY Adj. EBIT To Decrease By Approx. 20%; Group Sales Up 6.6%

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update